San Bernardino, CANCT06712407Now EnrollingIRB Ready

IgA Nephropathy Clinical Trial in San Bernardino, CA

Access cutting-edge iga nephropathy treatment through this clinical trial at a research site in San Bernardino. Study-provided care at no cost to qualified participants.

Sponsored by Calliditas Therapeutics AB

Quick Self-Assessment

See if you qualify for this San Bernardino location

Preparing your pre-screening questions...

Expert Care in San Bernardino

Access iga nephropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related iga nephropathy treatment provided free

Apply for This San Bernardino Location

Check if you qualify for this iga nephropathy clinical trial in San Bernardino, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Bernardino

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Bernardino site if eligible
  4. 4Begin participation

About This IgA Nephropathy Study in San Bernardino

The goal of this clinical trial is to assess the efficacy and safety of extended TARPEYO® (delayed-release budesonide capsules) treatment in adult patients with primary IgA nephropathy who have completed 9 months of TARPEYO® 16 mg once daily treatment in real-world clinical practice. The main question it aims to answer is: Is there a treatment benefit of TARPEYO® 16 mg QD extended use? Participants will * take part in this study for about 19 months * Have urine tests done * Have blood samples

Sponsor: Calliditas Therapeutics AB

Who Can Participate

Inclusion Criteria

Diagnosed IgAN with biopsy verification 2. Female or male participants ≥18 years of age 3. Completion of 9 months of treatment with TARPEYO® 16 mg QD at the Baseline visit 4. Access to retrospective local laboratory assessment data on UPCR and serum creatinine. Available retrospective data should include at least 1 assessment timepoint within 3 months prior to the first dose of TARPEYO® commercial treatment 5. Proteinuria at Screening based on 2 consecutive measurements (24-hour urine collection) after informed consent, separated by at least 1 week and calculated by the central laboratory. Both samples of the same parameter must show either of the following:
Proteinuria ≥0.5 g per day (≥500 mg per day) in 2 consecutive measurements, or
UPCR ≥0.3 g/gram in 2 consecutive measurements 6. On stable treatment with renin-angiotensin system (RAS) inhibitor therapy for at least 8 weeks prior to the Baseline visit. A stable dose is defined as a dose wit

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Bernardino?

Yes, this clinical trial (NCT06712407) has an active research site in San Bernardino, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

IgA Nephropathy Treatment Options in San Bernardino, CA

If you're searching for iga nephropathy treatment options in San Bernardino, CA, this clinical trial (NCT06712407) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Bernardino research site is actively enrolling participants for this clinical trial. You'll receive care from experienced iga nephropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all iga nephropathy clinical trials near you to find additional studies recruiting in your area.

More IgA Nephropathy Trials in San Bernardino, CA

See all iga nephropathy clinical trials recruiting in San Bernardino — not just this study.

Browse IgA Nephropathy Trials in San Bernardino

Ready to Join in San Bernardino?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Bernardino, CA